Identification of BM-MSCs. حسب Chen Lu (135200)

Effects of BM-MSCs on different types of lung cell death in different group. حسب Chen Lu (135200)

The global disease burden of <i><i>Klebsiella pneumoniae</i></i> associated LRI for both sexes in 204 countries and territories. (a) The number of deaths in 2021; (b) The EAPC of d... حسب Juanjuan Li (399633)

Inpatient utilization of anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

Outpatient utilization of anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

Utilization of anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

The expenditure on anticoagulants in the period of 2019-2023(million CNY). حسب Wei Luo (80175)

Comparison of postoperative NLR, PLR, and SII between the two groups. حسب Changxu Wang (17826805)

Pyrazole-Infused Metal Complexes: Anticancer Activity, DNA Cleavage, and Biophysical Insights into DNA/BSA Interactions حسب Tankadhar Behera (22267115)

الموضوعات:

Changes in growth characteristics (A = shoot fresh weight; B = shoot dry weight; C = root fresh weight; D = root dry weight) of M. stenopetala under drought conditions.... حسب Nadia Khater (22553166)

PVS_ratio changes, ΔPVS_ratio, for different radiation doses within each treatment period: 0M–3M(a), 3M–12M(b), and 12M–FollowUp(c). حسب Ruitian Song (11045127)

PVS_volume changes, ΔPVS_volumes, for various radiation doses within each treatment period: 0M–3M(a), 3M–12M(b), and 12M–FollowUp(c). حسب Ruitian Song (11045127)

Summary of miRNAs sequencing data quality. حسب Zhaowen Tan (12283502)

"…</p><p>Results</p><p>1) Hemodynamic tests revealed that the blood pressure of SHRs in the BFRT decreased significantly and that the blood pressure level of SHRs in the BFRT decreased more significantly than that of the simple resistance training groups did (P < 0.05). 2) Cardiac function tests revealed that the EF, FS, and MV E/A of SHRs in the BFRT significantly increased, whereas the HR, IVSd, IVSs, LVIDd, LIVDs, LVPWd, LVPWs and LV mass significantly decreased (P < 0.05). 3) Transcriptome sequencing revealed 9 differentially expressed miRNAs in the BFRT group compared with the SHR-SED group (2 miRNAs were significantly upregulated, and 7 miRNAs were significantly downregulated), with P < 0.05 and |log2FoldChange| ≥ 1 used as the criteria for differential significance. …"

The miRNA target genes. حسب Zhaowen Tan (12283502)

"…</p><p>Results</p><p>1) Hemodynamic tests revealed that the blood pressure of SHRs in the BFRT decreased significantly and that the blood pressure level of SHRs in the BFRT decreased more significantly than that of the simple resistance training groups did (P < 0.05). 2) Cardiac function tests revealed that the EF, FS, and MV E/A of SHRs in the BFRT significantly increased, whereas the HR, IVSd, IVSs, LVIDd, LIVDs, LVPWd, LVPWs and LV mass significantly decreased (P < 0.05). 3) Transcriptome sequencing revealed 9 differentially expressed miRNAs in the BFRT group compared with the SHR-SED group (2 miRNAs were significantly upregulated, and 7 miRNAs were significantly downregulated), with P < 0.05 and |log2FoldChange| ≥ 1 used as the criteria for differential significance. …"

Differential miRNA target gene pathway enrichment bubble map. حسب Zhaowen Tan (12283502)

The global disease burden of <i><i>Klebsiella pneumoniae</i></i> associated LRI for both sexes in 204 countries and territories. (a) The number of DALYs in 2021; (b) The EAPC of DA... حسب Juanjuan Li (399633)

Bar charts showing the numbers of significantly differentially expressed genes for the different contrasts. حسب Gillian P. McHugo (8965919)

"…<p>The extent of the bar above and below 0 on the vertical axis indicates the numbers of significantly differentially expressed genes (DEGs; B-H <i><i>P</i></i><sub>adj.…"

Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

Crude and residence-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)